CK-MB (NAC-ACT)
K-Number: K951223 · 1995-12-26
Advertisement
Device Summary
Frequently Asked Questions
What is the CK-MB (NAC-ACT)?
CK-MB (NAC-ACT) is a medical device that received FDA 510(k) clearance on 1995-12-26. The listed applicant is Randox Laboratories, Ltd.. The 510(k) number is K951223.
When did CK-MB (NAC-ACT) receive FDA 510(k) clearance?
CK-MB (NAC-ACT) received FDA 510(k) clearance on 1995-12-26, under 510(k) number K951223.
Who is the listed applicant for CK-MB (NAC-ACT)?
The FDA 510(k) record lists Randox Laboratories, Ltd. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CK-MB (NAC-ACT)?
The FDA product code for CK-MB (NAC-ACT) is CGS.
Other records listing Randox Laboratories, Ltd. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: CGS)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement